Angiotensin converting enzyme inhibitors – fosinopril
Last updated on August 26, 2024
|
Generic name |
fosinopril |
|---|---|
|
Strength |
10 mg, 20 mg |
| Form | tablet |
|
Special Authority criteria |
Approval period |
|---|---|
| 1. Treatment failure on optimal doses of, or intolerance to, ramipril.
OR 2. Complex patient requiring medications for co-existing chronic condition(s). |
Indefinite |
Practitioner exemptions
Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
- Paediatric
- Paediatrics Cardiology
Special notes
- Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.
Special Authority request form(s)
- Log in to eForms
- 5328—General Special Authority Request